Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Welch Allyn, Applied Spectral Imaging to Develop Retinal Imaging Technology
Apr 2000
SKANEATELES FALLS, N.Y., April 28 -- Welch Allyn Inc. and Applied Spectral Imaging Ltd. of Israel have agreed to jointly develop portable retinal imaging diagnostic products able to detect retinal diseases that may lead to blindness. The companies plan to use Applied Spectral Imaging's proprietary SpectraCube spectral imaging technology to identify and track the progression of retinal eye disease.
Under the terms of the agreement, Welch Allyn will make investments in Applied Spectral Imaging in accordance with product development milestones. The agreement also assigns to Welch Allyn the marketing rights for the jointly developed products. Financial terms of the agreement were not disclosed.
According to the Applied Spectral Imaging, SpectraCube separates the spectral content of light reacting with retinal tissue to provide a multi-dimensional database that can be used for image enhancement and analysis. The company asserts that spectral retinal imaging provides information not obtainable using existing techniques on key parameters of the retina, such as oxygen saturation -- an early indicator of most retinal diseases.

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.